{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:44:21Z","timestamp":1775123061423,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Pathology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.carpath.2024.107669","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T09:46:34Z","timestamp":1718185594000},"page":"107669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A pathological study on the efficacy of Syk inhibitors in a Candida albicans-induced aortic root vasculitis murine model"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1132-6695","authenticated-orcid":false,"given":"Nanae","family":"Asakawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Oharaseki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Yokouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohito","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.carpath.2024.107669_bib0001","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1542\/peds.54.3.271","article-title":"A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan","volume":"54","author":"Kawasaki","year":"1974","journal-title":"Pediatrics"},{"key":"10.1016\/j.carpath.2024.107669_bib0002","first-page":"681","article-title":"General pathology of Kawasaki disease: on the morphological alterations corresponding to the clinical manifestations","volume":"30","author":"Amano","year":"1980","journal-title":"Acta Pathol Jpn"},{"key":"10.1016\/j.carpath.2024.107669_bib0003","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.carpath.2018.10.005","article-title":"Expression of tenascin C in cardiovascular lesions of Kawasaki disease","volume":"38","author":"Y","year":"2019","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.carpath.2024.107669_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2020.107303","article-title":"The pathology of Kawasaki disease aortitis: a study of 37 cases","volume":"51","author":"Sato","year":"2021","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.carpath.2024.107669_bib0005","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation."},{"key":"10.1016\/j.carpath.2024.107669_bib0006","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","article-title":"Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease","volume":"13","author":"Kobayashi","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2024.107669_bib0007","first-page":"523","article-title":"Experimental Candida-induced arteritis in mice\u2013 relation to arteritis in Kawasaki disease","volume":"250","author":"Murata","year":"1987","journal-title":"Prog Clin Biol Res"},{"issue":"5","key":"10.1016\/j.carpath.2024.107669_bib0008","first-page":"S9","article-title":"Murine model of Kawasaki disease induced by Mannoprotein-\u03b2-Glucan complex, CAWS, obtained from Candida albicans","volume":"57","author":"Ohno","year":"2004","journal-title":"Jpn J Infect Dis"},{"issue":"1","key":"10.1016\/j.carpath.2024.107669_bib0009","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.carpath.2014.08.005","article-title":"JNK is critical for the development of Candida albicans-induced vascular lesions in a mouse model of Kawasaki disease","volume":"24","author":"Yoshikane","year":"2015","journal-title":"Cardiovasc Pathol"},{"issue":"2","key":"10.1016\/j.carpath.2024.107669_bib0010","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0889-857X(21)00977-7","article-title":"Animal models of vasculitis. Lessons we can learn to improve our understanding of Kawasaki disease","volume":"14","author":"Lehman","year":"1988","journal-title":"Rheum Dis Clin North Am"},{"issue":"5","key":"10.1016\/j.carpath.2024.107669_bib0011","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1161\/ATVBAHA.110.216325","article-title":"Nod1 ligands induce site-specific vascular inflammation","volume":"31","author":"Nishio","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.carpath.2024.107669_bib0012","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/s10165-009-0250-5","article-title":"Administration of human immunoglobulin suppresses development of murine systemic vasculitis induced with Candida albicans water-soluble fraction: an animal model of Kawasaki disease","volume":"20","author":"Takahashi","year":"2010","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.carpath.2024.107669_bib0013","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3109\/14397595.2013.854061","article-title":"The role of TNF-\u03b1 in a murine model of Kawasaki disease arteritis induced with a Candida albicans cell wall polysaccharide","volume":"24","author":"Oharaseki","year":"2014","journal-title":"Mod Rheumatol"},{"issue":"2","key":"10.1016\/j.carpath.2024.107669_bib0014","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/14397595.2019.1601852","article-title":"Recognition of alpha-mannan by dectin 2 is essential for onset of Kawasaki disease-like murine vasculitis induced by Candida albicans cell-wall polysaccharide","volume":"30","author":"Oharaseki","year":"2020","journal-title":"Mod Rheumatol"},{"issue":"9","key":"10.1016\/j.carpath.2024.107669_bib0015","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1172\/JCI123778","article-title":"Dectin-2\u2013induced CCL2 production in tissueresident macrophages ignites cardiac arteritis","volume":"129","author":"Miyabe","year":"2019","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.carpath.2024.107669_bib0016","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0006-291X(88)80401-7","article-title":"Characterization of partially purified cytosolic protein-tyrosine kinase from porcine spleen","volume":"152","author":"Sakai","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"issue":"13-14","key":"10.1016\/j.carpath.2024.107669_bib0017","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.drudis.2010.05.001","article-title":"Spleen tyrosine kinases: biology, therapeutic targets and drugs","volume":"15","author":"Riccaboni","year":"2010","journal-title":"Drug Discov Today"},{"issue":"6","key":"10.1016\/j.carpath.2024.107669_bib0018","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.kint.2019.12.014","article-title":"Spleen tyrosine kinase inhibition is an effective treatment for established vasculitis in a pre-clinical model","volume":"97","author":"McAdoo","year":"2020","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.carpath.2024.107669_bib0019","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1038\/bcj.2014.53","article-title":"Depletion of STAT5 blocks TEL\u2013SYK-induced APMF-type leukemia with myelofibrosis and myelodysplasia in mice","volume":"4","author":"Sprissler","year":"2014","journal-title":"Blood Cancer J"},{"issue":"12","key":"10.1016\/j.carpath.2024.107669_bib0020","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1002\/art.38851","article-title":"Effects of fostamatinib, an oral spleen tyrosine kinase inhibitor, in rheumatoid arthritis patients with an inadequate response to methotrexate","volume":"66","author":"Weinblatt","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.carpath.2024.107669_bib0021","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s40265-018-0927-1","article-title":"Fostamatinib: first Global Approval","volume":"78","author":"Markham","year":"2018","journal-title":"Drugs"},{"issue":"19","key":"10.1016\/j.carpath.2024.107669_bib0022","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1182\/blood-2018-11-852491","article-title":"Fostamatinib for the treatment of chronic immune thrombocytopenia","volume":"133","author":"Connell","year":"2019","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.carpath.2024.107669_bib0023","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1021\/jm500228a","article-title":"Discovery of GS-9973, a selective and orally efficacious inhibitor of spleen tyrosine kinase","volume":"8:57","author":"Currie","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.carpath.2024.107669_bib0024","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.taap.2007.03.027","article-title":"Immunotoxicity assessment for the novel Spleen tyrosine kinase inhibitor R406","volume":"221","author":"Zhu","year":"2007","journal-title":"Toxicol Appl Pharmacol"},{"issue":"8","key":"10.1016\/j.carpath.2024.107669_bib0025","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/jbmr.3449","article-title":"Second-generation SYK inhibitor entospletinib ameliorates fully established inflammation and bone destruction in the Cherubism Mouse Model","volume":"33","author":"Yoshimoto","year":"2018","journal-title":"J Bone and Miner Res"},{"key":"10.1016\/j.carpath.2024.107669_bib0026","article-title":"A model of left ventricular dysfunction complicated by CAWS arteritis in DBA\/2 mice","volume":"2012","author":"Hirata","year":"2012","journal-title":"Int J Vasc Med"},{"key":"10.1016\/j.carpath.2024.107669_bib0027","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpeds.2020.05.034","article-title":"Epidemiology, treatments, and cardiac complications in patients with Kawasaki disease: the Nationwide Survey in Japan, 2017-2018","volume":"225","author":"Ae","year":"2020","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.carpath.2024.107669_bib0028","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nbt1358","article-title":"A quantitative analysis of kinase inhibitor selectivity","volume":"26","author":"Karaman","year":"2008","journal-title":"Nat Biotechnol"}],"container-title":["Cardiovascular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880724000656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880724000656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T22:30:39Z","timestamp":1722897039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054880724000656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":28,"alternative-id":["S1054880724000656"],"URL":"https:\/\/doi.org\/10.1016\/j.carpath.2024.107669","relation":{},"ISSN":["1054-8807"],"issn-type":[{"value":"1054-8807","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pathological study on the efficacy of Syk inhibitors in a Candida albicans-induced aortic root vasculitis murine model","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carpath.2024.107669","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107669"}}